ClinicalTrials.gg
CompletedNCT02536872Updated Oct 17, 2016

A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder

An observational study in Urogynaecology, sponsored by Medway NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to female participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2016-10-17.

Sponsored by Medway NHS Foundation Trust · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years to 100 Years
Sex
Female
01

Study summary

The concept of organisms living on or in the human body without causing overt signs of an infection is common in medicine and has been termed a microbiome. Urine from patients with Overactive bladder (OAB) grows different organisms from controls without OAB. However, it is not known if the bacteria that have been identified are innocent commensals or pathogenic organism responsible for the symptoms of OAB. Previous data suggests that treatment with antibiotics does lead to an improvement in overactive bladder symptoms in a large number of patients. On this basis the investigators now treat are patients with similar antibiotic regimes. If antibiotics improve symptoms it would be expected that they would return the microbiome back to how it is in patients without OAB. This study aims to identify the effects of antibiotics on the urinary microbiome and to identify/confirm if antibiotic treatments cause improvement in OAB.

Read the detailed description

This study is a consecutive cohort study. Subjects will be recruited from Urogynaecology clinics at Medway NHS Foundation Trust. Patients will be identified from previous records and also prospectively from new patients. They will be sent information regarding the trial before attending their first appointment.

Patients attending urogynaecology clinics will provide a fresh clean catch specimen of urine. A conventional hospital Mid stream speciemn of urine (MSU) will be sent. Urine will be dipsticked for nitrites and leucocyte esterase. The urine will then be spun and undergo microscopy using a special stain (looking for intracellular organisms in shed urothelial cells). The urothelial cells will be cleaned with antibiotics. The cells will then be lysed and their contents cultured. The contents will undergo Polymerase Chain Reaction (PCR) sequencing to identify bacteria. Sensitivity testing will be used to assess and deliver the appropriate antibiotic regime.

Women will be treated with a 6 week course of antibiotics as per their usual treatment. Broad spectrum antibiotics will be prescribed to all women based on the previous successful therapeutic regime as described by Vijaya. Six weeks after the end of antibiotic therapy patients will be reviewed and their urine retested.

02

Conditions studied

  • Urogynaecology

Keywords

  • infection overactive bladder
03

In context

Lead sponsor

Medway NHS Foundation Trust is the lead sponsor of 13 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

women with overactive bladder syndrome

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. > age 18 years
  2. Negative urine dipstick (nitrites) and culture (x10 to the power 5 colony forming units) x105 cfu
  3. Idiopathic overactive bladder as per International Continence Society definition

Exclusion criteria

Exclusion Criteria:

  1. Patients treated with antibiotics for any infection within the last 6 weeks.
  2. Patients with known multiple sclerosis, stroke, spinal injury, or other neurological disease
  3. Urinary tract infection diagnosed by nitrite positivity or positive urine culture (x105 cfu)
  4. Undiagnosed macroscopic or persistent microscopic haematuria needing investigation
  5. Previous or current cancer of the urogenital tract.
  6. to multiple antibiotics
  7. No suitable oral antibiotic regime
  8. Patients unable to understand the study or complete the questionnaires.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No

Interventions

  • OtherNone - this is a prospective observational study. Patients will be prescribed their usual treatment (antibiotics) and the effect on urine studied
06

What researchers measure

Primary outcomes

  1. Change in bladder microbiology in patients treated with antibiotics.

    The number and type of different organisms will be quantified and compared to the pre treatment organisms

    Time frame: 6 weeks

Secondary outcomes

  1. Change in the overactive bladder questionnaire (OAB-q) before and after treatment

    questionnaire

    Time frame: 6 weeks

  2. Change in Patient Perception of Bladder Condition (PPBC)

    questionnaire

    Time frame: 6 weeks

  3. To identify adherence to the treatment regime

    Patients will be asked to identify if they took all of the antibiotics; 75% of the time; 50 or 25%

    Time frame: 6 weeks

  4. To identify adverse effects of the treatment

    Patients will be asked report side effects of antibiotic treatment

    Time frame: 6 weeks

  5. Changes in symptoms using (change from baseline to assessment)

    Measured by the International consultation on Incontinence female lower urinary tract syptome questionnaire. (ICI FLUTs)

    Time frame: 6 weeks

07

Study locations

1 site
  • Medway Hospital
    Gillingham, Kent ME17 3AN, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2015, a primary completion of Sep 2016 and a completion of Oct 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2015
First posted
Sep 1, 2015
Start
Oct 2015
Primary completionActual
Sep 2016
CompletionActual
Oct 2016
Last update
Oct 17, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02536872
Lead sponsor
Medway NHS Foundation Trust
Responsible party
Professor Jonathan Duckett (Consultant Urogynaecologist, Medway NHS Foundation Trust) — Principal investigator
First posted
Sep 1, 2015
Start date
Oct 2015
Primary completion
Sep 2016
Completion
Oct 2016
Last update
Oct 17, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion